Neurogene (NGNE) Other Operating Expenses (2013 - 2019)

Neurogene (NGNE) has 3 years of Other Operating Expenses data on file, last reported at $47.7 million in Q3 2019.

• Quarterly Other Operating Expenses changed N/A year-over-year to $47.7 million in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $47.7 million (changed N/A YoY) and the FY2019 annual result came in at $47.7 million, changed N/A from the prior year.
• Other Operating Expenses advanced to $47.7 million in Q3 2019, from -$1350.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $47.7 million in Q3 2019 to a low of $47.7 million in Q3 2019.